Loading
PDBj
メニューPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help
PDB: 6 件

6FYL
DownloadVisualize
BU of 6fyl by Molmil
X-ray structure of CLK2-KD(136-496)/CX-4945 at 1.95A
分子名称: 5-[(3-chlorophenyl)amino]benzo[c][2,6]naphthyridine-8-carboxylic acid, Dual specificity protein kinase CLK2
著者Kallen, J.
登録日2018-03-12
公開日2018-07-18
最終更新日2024-01-17
実験手法X-RAY DIFFRACTION (1.95 Å)
主引用文献X-ray Structures and Feasibility Assessment of CLK2 Inhibitors for Phelan-McDermid Syndrome.
ChemMedChem, 13, 2018
6FYK
DownloadVisualize
BU of 6fyk by Molmil
X-Ray structure of CLK2-KD(136-496)/Indazole1 at 2.39A
分子名称: (2~{S})-4-methyl-1-[5-(3-methyl-2~{H}-indazol-5-yl)pyridin-3-yl]oxy-pentan-2-amine, Dual specificity protein kinase CLK2
著者Kallen, J.
登録日2018-03-12
公開日2018-07-18
最終更新日2024-01-17
実験手法X-RAY DIFFRACTION (2.39 Å)
主引用文献X-ray Structures and Feasibility Assessment of CLK2 Inhibitors for Phelan-McDermid Syndrome.
ChemMedChem, 13, 2018
6FYI
DownloadVisualize
BU of 6fyi by Molmil
X-ray Structure of CLK2-KD(130-496)/TG003 at 2.6A
分子名称: (1~{Z})-1-(3-ethyl-5-methoxy-1,3-benzothiazol-2-ylidene)propan-2-one, Dual specificity protein kinase CLK2
著者Kallen, J.
登録日2018-03-12
公開日2018-07-18
最終更新日2024-01-17
実験手法X-RAY DIFFRACTION (2.6 Å)
主引用文献X-ray Structures and Feasibility Assessment of CLK2 Inhibitors for Phelan-McDermid Syndrome.
ChemMedChem, 13, 2018
6KHE
DownloadVisualize
BU of 6khe by Molmil
Crystal structure of CLK2 in complex with CX-4945
分子名称: 5-[(3-chlorophenyl)amino]benzo[c][2,6]naphthyridine-8-carboxylic acid, Dual specificity protein kinase CLK2
著者Lee, J.Y, Yun, J.S, Jin, H, Chang, J.H.
登録日2019-07-15
公開日2019-10-02
最終更新日2024-03-27
実験手法X-RAY DIFFRACTION (2.8 Å)
主引用文献Structural Basis for the Selective Inhibition of Cdc2-Like Kinases by CX-4945.
Biomed Res Int, 2019, 2019
3NR9
DownloadVisualize
BU of 3nr9 by Molmil
Structure of human CDC2-like kinase 2 (CLK2)
分子名称: (5Z)-5-(quinolin-6-ylmethylidene)-2-[(thiophen-2-ylmethyl)amino]-1,3-thiazol-4(5H)-one, Dual specificity protein kinase CLK2
著者Chaikuad, A, Savitsky, P, Krojer, T, Muniz, J.R.C, Filippakopoulos, P, Rellos, P, Keates, T, Fedorov, O, Pike, A.C.W, Eswaran, J, Berridge, G, Phillips, C, Zhang, Y, von Delft, F, Weigelt, J, Arrowsmith, C.H, Edwards, A.M, Bountra, C, Knapp, S, Structural Genomics Consortium (SGC)
登録日2010-06-30
公開日2010-08-25
最終更新日2023-09-06
実験手法X-RAY DIFFRACTION (2.89 Å)
主引用文献Structure of human CDC2-like kinase 2 (CLK2)
To be Published
5UNP
DownloadVisualize
BU of 5unp by Molmil
Structure of CDC2-Like Kinase 2 (CLK2) in Complex with Compound T-025 [N2-methyl-N4-(pyrimidin-2-ylmethyl)-5-(quinolin-6-yl)-7H-pyrrolo[2,3-d]pyrimidine-2,4-diamine]
分子名称: Dual specificity protein kinase CLK2, N~2~-methyl-N~4~-[(pyrimidin-2-yl)methyl]-5-(quinolin-6-yl)-7H-pyrrolo[2,3-d]pyrimidine-2,4-diamine
著者Klein, M.G, Tjhen, R.
登録日2017-01-31
公開日2018-05-09
最終更新日2024-03-06
実験手法X-RAY DIFFRACTION (2.92 Å)
主引用文献A novel CLK inhibitor exhibits anti-tumor efficacies via modulating pre-mRNA splicing and targeting a MYC-dependent vulnerability
Embo Mol Med, 2018

223532

件を2024-08-07に公開中

PDB statisticsPDBj update infoContact PDBjnumon